A Multicenter, Double-Blind, Randomized, Parallel-Group, Placebo Controlled Phase 2 Study of Once-Daily Subcutaneous Methylnaltrexone (MNTX) in the Treatment of Opioid-Induced Constipation During Rehabilitation After Orthopedic Procedures.
Phase of Trial: Phase II
Latest Information Update: 20 Nov 2015
At a glance
- Drugs Methylnaltrexone bromide (Primary)
- Indications Constipation
- Focus Therapeutic Use
- 31 May 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 31 May 2011 Actual end date (Jan 2009) added as reported by ClinicalTrials.gov.
- 29 Dec 2010 New trial record